SynthesisBMC infectious diseases2025
HIV and tuberculosis co-infection in non-European migrants in Europe: a systematic review and meta-analysis.
Synthesis in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEven though HIV-TB co-infection is an emerging public health issue among migrants in European countries, the number of related articles has shown a decreasing trend.
methodsTo better estimate the extent of this problem, we analyzed 34 articles reporting both prevalence and odds ratio for HIV-TB co-infection in migrants in European countries. Heterogeneity analysis was conducted to assess potential bias, and a random-effects model was used to calculate the effect size.
resultsThe overall prevalence of HIV-TB co-infection was 9% (95%CI: 7% - 11%) in foreign-born individuals, with higher rates observed in specific subgroups: 14% (95%CI: 5% - 33%) in those from Sub-Saharan Africa, which is higher than the overall average, and 4% (95%CI: 2% - 7%) in those from Latin America, which is lower than the overall average. Compared to the native-born European population, foreign-born individuals had a twofold increased risk of HIV-TB co-infection, with a threefold increased risk for those from Sub-Saharan Africa.
conclusionsOur meta-analysis results highlight the disproportionate burden of HIV-TB co-infection among foreign-born people in Europe, particularly those from Sub-Saharan Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.